Drug news
Homechoice Claria peritoneal dialysis (APD) system receives CE Mark- Baxter
Baxter International Inc.announced completion of CE marking (market approval) in Europe for Homechoice Claria, an automated peritoneal dialysis (APD) system integrated with the Sharesource web-based connectivity platform. The APD system is designed with user-friendly features and secure two-way connectivity so healthcare providers can have increased visibility to monitor their patients' home peritoneal dialysis (PD) treatments and adjust prescriptions as necessary. PD is a therapy option performed primarily at home by end-stage renal disease patients.
Baxter plans to initiate the commercial launch of Homechoice Claria with Sharesource in select European and Asian countries in the first half of 2015.